Press Release
December 3, 2007
Boca Raton, Florida
Contact: www.medgen.com
Med Gen Reports 191% Increase in Year to Date Revenue
BOCA RATON, Fla.--(BUSINESS WIRE)--Med Gen Inc. (OTCBB:MGEN), manufacturers of nationally branded OTC healthier life products and specialty financial services, reports that unaudited revenue as of November 30, 2007 was $360,000, exceeding the same period in 2006 by approximately 191%. Liquidity in the form of cash on hand or cash equivalents exceeds $725,000.
“As we enter December, the last month of our 1st quarter, we should start to evidence increased sales from the beginnings of our planned advertising and commercial TV spots for Fabulust®, Snorenz® and Good Nights Sleep®”, said Paul S. Mitchell, company President/COO. “Our largest increase in sales should come during the March quarter when all commercials will be airing. On this issue, Painenz® commercials will air in Chicago and Boston markets on the Lifetime Channel and A&E Channel the week of December 3rd as a result of our contractual arrangement with Home Shopping Group, Inc.”
About Med Gen Inc.
Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray's the Way ("STW"). It is best known for producing the world's first patented liquid spray snoring relief formula, Snorenz®. Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep® and the UnDiet® system into its family of brands. FabulustT, the company's newest product, a female sexual stimulant, is scheduled to launch in the late fall of 2007. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. Recently, the company formed a joint venture to market TheraPedic CST an innovative and patented innersole, that amongst other attributes, cools and comforts the feet. The company markets its products to distributors, major chain and drug stores, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names. The Company also offers specialty services to small emerging public companies in similar fields as a way of adding assets to its base business. Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol "MGEN". For information contact Investor Relations 561-750-1100 or www.medgen.com.
This Press Release contains or incorporates by reference "forward looking statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words "believes", "suggests", "anticipates", "plans", "expects", and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.